Diseases, Disorders information » Immunizations

Prevention of RSV

Disorders — Thu, 04 Jun 2009 17:02:41 +0000

I’ll briefly talk about prevention of RSV, respiratory syncytial virus. There are two products available and these are both passive immunization. These can be given to children less than 2 years of age. Those with chronic lung disease – and that’s defined as medical therapy for the chronic lung disease in the past six months. These are preemies, kids born less than 32 weeks. One product is palivizumab, also known as Synagis. It’s a monoclonal RSV antibody, purified antibody, and it’s given intramuscularly. We give it monthly during the RSV season because one dose only lasts a month. It does result in a 50% reduction in hospitalization due to RSV. A precaution is don’t give it to children with cyanotic congenital heart disease. That’s due to experience with the next product, which is RespiGam, or RSV-IGIV. This is a hyperimmune globulin, so it’s not a purified monoclonal antibody and this needs to be given monthly during RSV season. It’s given intravenously, not intramuscularly, so you have to start an IV to give it. It also results in about a 50% reduction in hospitalization due to RSV. But the drawback is that you do need to start an IV and that can be cumbersome. Contraindication is, a definite contraindication due to cyanotic congenital heart disease. Administration of RSV-IGIV in that situation, in children with cyanotic congenital heart disease, results in increased risk of death and that’s why as a precaution the monoclonal antibody is not given in that situation. Since this is a polyclonal antibody, it may result in vaccine interference as well because it does contain antibodies against measles and varicella so you need to pay attention to that vaccine interference and give additional doses of MMR and varicella vaccine after the antibody has worn off.
Viagra Super Active
Finally I’m just going to talk briefly about bite wounds and some specific situations in that regard. In general, with a bite wound, you need to clean the wound and debride the wound of any devitalized tissue, update routine immunizations such as tetanus and hepatitis B for human bites only, and assess HIV risk for human bites. Then you need to assess the rabies risk. And in terms of assessing the rabies risk, those animal bites that are high risk for transmitting rabies are any bat bite or bat contact, a rabid or suspected rabid dog or cat – that’s obvious – and any skunk, raccoons, foxes, most other carnivores or woodchucks in rabies-endemic areas may transmit rabies virus. In terms of unknown risk in an escaped dog or cat, a bite from those animals may result in rabies and for that you should contact the local public health authorities. They would know whether there is any rabies in the area, whether that would be a risk. Low-risk animal bites would be those from livestock, ferrets, rodents or rabbits or hares. Low risk. Bunnies are low risk.
Canadian viagra
In terms of rabies prophylaxis there are two things to do in addition to cleaning the wound and local wound care and that’s giving the rabies immune globulin; giving as much as possible of the dose, infiltrating the wound area, and then giving the rabies vaccines. There are three different vaccines from different manufacturers. They are not important to know, but it is important to know the time that you should give rabies vaccine, when it’s indicated. It’s a five dose series and there’s the schedule.
Cheap Amoxicillin
In terms of antibiotic therapy after bite wounds, you should give antibiotics as prophylaxis when it’s indicated, following a bite wound. That would be with increased infection risk. That would be when there has been a moderate or severe wound, you get devitalized tissue which can serve as a possible nidus of infection where host defenses can’t get into. Puncture wounds; this will inoculate areas deep in areas that may not be easily cleansed, facial, hand, foot or genital bite, these key areas, immunocompromised subjects would be at increased risk of infection. And the organisms that you would suspect as causing infection from a dog or cat bite would include staph aureus, strep, Pasteurella, and Capnocytophaga. From human bites, strep, staph aureus. So the recommended antibiotics would be either amoxicillin clavulanic acid or Augmentin, cefuroxime or the combination of trimethoprim-sulfa and clindamycin.

Meningococcal vaccine

Disorders — Tue, 02 Jun 2009 14:21:07 +0000

Meningococcal vaccine is an inactivated polysaccharide vaccine. Contains some of the strains of meningococcus, groups A, C, Y and W135 but does not contain group B, which is quite common. Again, it has local reactions and is indicated at 2 years of age or greater – not less than that because it’s not immunogenic – and to immunocompromised subjects at higher risk of invasive meningococcal disease; those with asplenia, those with terminal complement component deficiencies, and those at increased risk of exposure if there’s an epidemic, and travelers to endemic areas.
Human Growth Hormone online
Immunization of household contacts of immunocompromised children. Just to review, no OPV. You should use IPV. Give influenza vaccine. You should know that varicella vaccines may rarely be transmitted person to person. That’s not a reason not to vaccinate. You should still give varicella vaccine in that situation, but it may be transmitted. MMR vaccine, however, is not transmitted person to person.
Cialis Soft Tabs online at discount canadian pharmacy.
I want to talk about some other special circumstances of immunization, with some of the newer vaccines; hepatitis A. You can prevent hepatitis A either with immune globulin and this is efficacious if given within two weeks of exposure. You can also give it pre-exposure and, depending on the dose, protect for 3-6 months after giving a dose of immune globulin. But this does provide relatively short term protection and the supply may be limited. Therefore inactivated hepatitis A vaccine may be given. There are two different vaccines and I’ve listed some of the details regarding the dose and the differences between them. Most important to know, though, is that hepatitis A vaccine may be given as an active vaccination and that it needs to be given at 2 years of age or older. In terms of the inactivated hepatitis A vaccine, 5-15% have mild local reactions, have excellent immunogenicity and you can see a very high rate of efficacy with hepatitis A vaccination. The pediatric indications; should be given 2 years of age and older, to be given to those travelers to endemic areas, if there is a hepatitis outbreak, for those at increased risk of acquiring hepatitis A or those at increased risk from liver disease. So anybody with chronic liver disease, you wouldn’t want them to take another hit by getting hepatitis A and they should be protected.

Immunization of immunocompromised children

Disorders — Sat, 30 May 2009 16:45:32 +0000

Next we are going to talk about a special category of children and talk about immunization of immunocompromised children. In general, immunocompromising conditions are shown on this slide and those are subjects with malignancies, systemic steroids – 1 to 2 mg/kg per day of prednisone or equivalent, or a total of 20 mg per day – congenital immunodeficiencies, HIV infection or transplant recipients. That’s the population I’m talking about. With immunocompromised children, as a general rule, killed vaccines, inactivated vaccines, should be administered routinely and where you need to think about it is in regards to live vaccine. In general, we’ve talked about how they are generally contraindicated. Definitely should give IPV and not OPV for the subject and household contacts. The exception to live vaccines is MMR, and what’s not in your handout, varicella vaccine. Also varicella vaccine as well as MMR vaccine may be given to HIV infected children unless they are severely immunocompromised. If they are severely immunocompromised they should not receive MMR or varicella vaccine.
Cialis professional
Influenza vaccine may be indicated for immunocompromised children. Candidates for influenza vaccine include those with chronic diseases, immunocompromised individuals, and anyone at risk for Reye’s syndrome which may occur with influenza. And that would be, for example, subjects with JRA on long term aspirin therapy. And close contact of anybody with the above conditions and that’s because you can prevent them from coming in contact with influenza. Then age 6 months or older. Shouldn’t be used less than 6 months of age. The vaccine is inactivated, it’s trivalent, containing two strains of influenza A and one strain of influenza B. It changes yearly. You need to vaccinate yearly. The side effects of vaccination are mostly local reactions and the timing of vaccination should be in the fall of every year right before flu season starts. The schedule is here, included for completeness, but really I think if you know who should get influenza vaccine that’s the most important issue, not the exact schedule. You should know that it’s given greater than 6 months of age and that split virus only should be used less than 12 years of age, because that’s less reactagenic, less than 12 years of age. There is a whole virus and a split virus vaccine and both of those can be given after 12 years of age. There is no difference.
Antibiotics online
Pneumococcal vaccine consists of 23 different serotypes of pneumococcus that are included in the vaccine. The usual side effects are local reactions and low-grade fever. This should be administered to children who are at least 2 years of age and older, who have conditions such as HIV infection, asplenia and nephrotic syndromes, CFS leaks, malignancy. These are all subjects who are at increased risk of pneumococcal, invasive pneumococcal disease. And also those with chronic diseases are at risk as well.
Kamagra Oral Jelly

About catch-up immunization

Disorders — Thu, 07 May 2009 23:44:24 +0000

Again, we talked about catch-up immunization of the 11-12 year old age group. When they come into the office, pay attention to see if they’ve gotten hepatitis B vaccine in the past and then they should get three doses if they haven’t. In California, this is the first year that requires hepatitis B vaccine for school entry for junior high school.
Canadian viagra
Now we will move on and talk about common varicella vaccine. Varicella vaccine is a live virus vaccine, administered subcutaneously. It may result in some reactions. The most common reaction is a local reaction similar to other vaccines; pain, redness at the injection site, mild and goes away in a few days. But it also may result in very subclinical varicella. You can see a papulovesicular rash. This can be either localized to the injection site, or it can be generalized. In general, this is a very small number of lesions and this is what it looks like. This is localized to the injection site. You can just see this is at the injection site. This is ten days following immunization. A few papules. That one actually looks a little bit like a vesical to me, and that goes away in a few days. That’s the vaccine virus multiplying. The vaccine is immunogenic, greater than 95% immunogenicity and the efficacy – I split this up into two kinds of efficacy. One is absolute efficacy; 85% of subjects have prevention of varicella. The other 15% may have breakthrough disease but the breakthrough disease is also … there is some efficacy in breakthrough disease, in which case it’s milder than routine chicken pox which occurs in unvaccinated individuals. The rash is atypical. You get a reduction in skin lesions. Half the patients don’t even have vesicles and only a minority have fever. Recovery is more rapid in children who have chicken pox who have been previously vaccinated, compared to those who haven’t.
Cialis super active at canadian online pharmacy shop.
Contraindications and precautions to varicella vaccine are shown on this slide. Live virus vaccine; again, immunocompromised host – you need to think about that – pregnancy, neomycin anaphylactic or gelatin allergy that is in the vaccine, presence of passive antibody will interfere with vaccine take, and aspirin should be avoided after vaccination because of a theoretical risk of Reye’s syndrome which may occur with aspirin and wild type chicken pox.

The recommendations are for routine vaccination at 12-18 months of age. Catch-up immunization for subjects who are out of that age range who are still susceptible to chicken pox; one dose can be given 1-12 years of age. Older than 12 years of age you need two doses to achieve the same immunogenicity. A lot of issues have come up regarding duration of immunity to varicella vaccine. How long will subjects remain immune after vaccination? That’s not known, but ten year follow-up in this country, twenty year follow-up in Japan, so this vaccine does have a long duration of immunity. Further studies are in progress to determine if booster doses are needed. But it’s very reassuring that there has been no severity in breakthrough varicella over time, which would indicate waning immunity.
Viagra Soft Tabs
Next we’ll move on and talk about passive antibody and prevention of varicella. We’ll talk briefly about VZIG because really active vaccination with varicella is the way to go, but VZIG(Varicella Zoster Immune Globulin) may be administered as soon as possible, definitely within four days of exposure to varicella to subjects who meet three criteria. The three criteria are: susceptible to chicken pox, significant exposure, and high risk for complications. Susceptible to chicken pox means they have never had chicken pox in the past. Significant exposure, shown on this slide, household contact, face-to-face play, hospital roommate or newborn with maternal varicella five days prior to delivery, up to two days postpartum. Those subjects who are at increased risk for complications include those who are immunocompromised, a newborn with the above situation, and premature infants.

The hepatitis B vaccine

Disorders — Thu, 30 Apr 2009 19:11:17 +0000

And the hepatitis B vaccine is a purified vaccine, just containing the hepatitis B surface antigen. No other components. It’s an inactivated vaccine, no risk of acquiring hepatitis. It is produced in a yeast system so it does contain yeast protein, aluminum hydroxide as an adjuvant, as well as thimerosal. And if there’s time we’ll talk about the thimerosal issue which has resulted in some changes to the recommendations on the slides and in the syllabus, but these are very short term and for test-taking purposes we can just use the old schedule.
Cialis super active
The side effects of hepatitis B vaccine are mainly local side effects, local tenderness and these have an excellent vaccine response after immunization, greater than 95% immunogenicity in infants, greater than 90% efficacy and in general with this inactivated vaccine, giving the primary series of hepatitis B vaccine will result in at least an 8-10 year duration of immunity and this is still being followed up. But it looks very promising, in terms of long term immunity. In the future it may be required, but long duration immunity to date.
Generic viagra pharmacy
There are two different hepatitis B vaccines. In the past this has been very confusing in terms of different schedules, but for pediatrics – less than 20 years of age – there are two different vaccines but there is a unit dose for each of them, and so that really simplifies things. So the schedule for vaccination, for universal immunization, the routine recommendation is for infants of hepatitis B surface antigen-negative mother, to give a three -dose vaccine series – and there is a little bit of leeway in the recommendation – to give the first dose at two months, the second dose one to two months later, and the third dose at 6-18 months of age. Therefore you have these common schedules that you will see that fit within these guidelines; 0, 1 and 6 months, 2, 4 and 12 or 2, 4 and 6 months of age. The one caveat relates to preterm infants less than 2 kg do not have as good of an immune response to hepatitis B vaccine so the first dose should be given when they are 2 kg or two months of age. Now there has been the recent thimerosal issue which has occurred, with new recommendations in July of this year, to delay the first dose of hepatitis B vaccine to at least two months of age because it does contain thimerosal. That is a temporary issue. The manufacturers of hepatitis B vaccine should have thimerosal-free hepatitis B vaccine available within the next few months. If there is a cutting edge issue, it is interesting how these recommendations came about, but for taking the Pediatric Board, I would just follow these old recommendations.
Human Growth Hormone online
Now for infants of hepatitis B surface antigen-positive mothers, they need also to get hepatitis B immune globulin, H-BIG, within 12 hours of birth and this provides immediate antibody. In addition, hepatitis B vaccine should be given at 0, 1 and 6 months of age. The first dose within 12 hours of birth and this will result in sustained antibody production. The hepatitis B Vaccine and H-BIG may be administered simultaneously but they should be at separate sites and obviously with separate syringes. There is no changes regarding the thimerosal issue in regards to infants of hepatitis B surface antigen-positive mothers. Also no changes in instances of mothers who have unknown hepatitis B surface antigen status. These children should get hepatitis B vaccine at 0, 1 and 6 months of age. The mother should be screened. If they are hepatitis B surface antigen-negative, then they can just complete the series. If they are hepatitis B surface antigen-positive then they should receive hepatitis B immune globulin as soon as possible, and complete the vaccine series as well.

Different vaccines

Disorders — Tue, 28 Apr 2009 18:41:51 +0000

With the different vaccines there are different schedules. In general, you give a primary series of either two or three doses of H. flu type B vaccine and then you give a booster dose at 12-15 months. Now the thing that makes this a little more complicated is that one of these vaccines, the Merck product, you only give two doses for the primary series and you don’t need to give the third dose at six months of age. So these vaccines are interchangeable, however if you do interchange these vaccines you should err on the side of getting more vaccine doses rather than less. For example, if you give the first dose of PedvaxHIB at two months of age and then you switch over to HibTITER for the second dose, then you need to also give the third dose of HibTITER and then another dose at 12-15 months of age. Otherwise these vaccines are interchangeable.
Canadian kamagra
In terms of catch-up immunization with HIB vaccines, it’s important to know that the older one is, the less doses one needs of HIB vaccine. So that after 15 months of age you only need to give one dose at time zero and you don’t need to give a whole primary series, just the one dose.
Then you need to be aware of combination vaccines. HIB may occur not just alone as a single antigen, but may occur in combination with whole cell DTP vaccine, and this may result in a decreased number of immunizations at 2,4,6 and 12-18 months of age. However, remember, DTP vaccine, whole cell DTP vaccine, is not routinely recommended anymore. What’s preferred is the acellular pertussis component vaccine.
Abilify online at licensed online pharmacy.
Well, let’s move on and talk about the DTaP-HIB combination vaccine. Great idea, and unfortunately this is only approved for use at the fourth dose of a vaccine series only; 12-18 months of age. Do not give this vaccine at 2, 4 and 6 months of age. Do not give the combination vaccine. That’s wrong, it’s contraindicated, it’s not approved for use. There is a decreased immune response to the vaccine components when it is given at 2, 4, 6 months of age. And then there is the HIB and hepatitis B vaccine combination, and this can be useful to decrease the number of injections at 2 months, 4 months and 12 months of age. But in terms of knowing all the different vaccines and combinations that exist, it’s important to know that you do have choices and it’s important to know when these choices may be possible and when they shouldn’t be given.

Now I am going to move on and talk about hepatitis B vaccine and the strategy behind recommending universal immunization against hepatitis B. The rationale behind that is that hepatitis B does occur in this country. What we are most familiar with, though, is acute hepatitis B infection. Symptomatic infection which may result in death due to fulminant hepatitis; about 400 per year as shown on this slide from the CDC. Now what may also occur is asymptomatic infection with hepatitis B and whether it’s asymptomatic or symptomatic, chronic carrier carriage may occur following infection with hepatitis B. And this is where the main problem exists in terms of public health importance. Is that chronic carriers can get chronic disease, either death due to cirrhosis or death due to liver cancer, and if you add these up you can see that the chronic disease, death due to chronic liver disease, due to chronic carriers is ten times more important as a public health issue compared to death from acute symptomatic hepatitis B. That’s why it’s important to prevent chronic carriage. Where that enters into pediatrics is shown on this graph by the CDC, which is the inverse correlation between age and risk of having chronic carriage; that is, the younger the age, those who acquire hepatitis B at birth have a 90% risk of becoming chronic carriers and those who get hepatitis B at a year of age, 50% risk, and older children and adults only 5-10% risk of becoming a chronic carrier. Viagra Jelly online without prescription. So really, preventing hepatitis B at the youngest age can really have a major impact on preventing chronic carriage of hepatitis B and that’s where the main number of deaths occur. A lot of times it is said that, “Well, the kids that I’m treating, my population, aren’t at risk. They don’t have the classic risk factors for hepatitis B” and this slide from the CDC shows intensely investigated cases of acute hepatitis B. The usual risk factors that we are familiar with; IV drug use, high risk heterosexual or homosexual activity or needle stick. But you can see that 35-40% of cases of acute hepatitis B don’t have these classic risk factors and so everybody is at risk for hepatitis B whether they have the classic risk factor or not. Children especially are at risk of becoming chronic carriers. So because of this we do recommend universal immunization with hepatitis B vaccine.

The last part of MMR vaccine

Disorders — Tue, 21 Apr 2009 21:13:46 +0000

Finally, the last part of MMR vaccine; the R is for rubella vaccine and rubella vaccine is also a live virus vaccine. The strategy to prevent intrauterine infection in this country, to prevent congenital rubella syndrome, is to vaccinate everybody routinely. To do that you give the rubella vaccine, the live virus vaccine. The main reactions to be concerned about are an attenuated form of rubella. A mild rash, a low-grade fever, and in children sometimes you get some occipital or posterior auricular lymphadenopathy and arthralgia. In young women the rubella vaccine may be slightly more reactagenic, resulting in not only transient arthralgias but sometimes transient arthritis as well.
Female viagra
Precautions and contraindications are similar; pregnancy, immunocompromised – it might multiply more than you would want it to in that situation – and immune globulin will interfere with vaccine take. Excellent seroconversion is obtained with rubella vaccine. Again, a graph from the CDC shows a marked reduction in the cases of rubella in this country. It’s been quite successful.
Cefaclor online without prescription.
So now we are going to move on from MMR vaccine and move on to H. flu type B vaccine. I haven’t talked much about the science behind a lot of these vaccines and that’s because that’s not important for test-taking purposes. However, with H. flu type B vaccine, that’s different. So I am going to spend a little bit talking about the science behind it. The important thing with H. flu type B in terms of immunity is immunity to the polysaccharides. However if you take the plain polysaccharide and you use that as a vaccine, it’s very weak. You get a very weak antibody response in infants and really don’t get a very good antibody response until 18-24 months of age. If you take this polysaccharide and you bind it to a protein, then it becomes a T-cell dependent immunogen. Canadian viagra for sale. It has enhanced immunogenicity, especially in infants, you get a better immune response and you get a booster response if you give repeated doses of vaccine or if you get exposure to H. flu type B. Because of this has been remarkably successful, as you’ll see. This is being applied to other vaccines and development of other vaccines, such as improved vaccine against pneumococcus, improved vaccine against meningococcus. And because of that, because you will see it in the future, this is the kind of thing, that basic science sort of thing, that actually may be tested because I think it is important to understand that this technology is improving vaccines.
Men with erectile dysfunction issues find viagra soft tablets a reliable solution.
So there are several different vaccines in general. It’s not important to know the main differences between them, but there are different manufacturers of the vaccine. The polysaccharide is linked to different protein carriers. Most of these have been used before so there is a lot of clinical experience with them, and that’s why they have been chosen. But all of them are very safe vaccines, very minor reactions, local reactions. Rarely you get a low-grade fever after vaccination with the routinely used HIB vaccines. Again, these have been remarkably successful. The conjugate vaccines were introduced in 1988 and then in 1990 they were recommended for infants. You can see invasive H. flu type B disease in this country more than a 95% reduction. This has been quite a success story.

We are going to move on to MMR vaccine

Disorders — Fri, 13 Feb 2009 23:37:35 +0000

We are going to move on to MMR vaccine. The first part of the M is measles vaccine. And measles vaccine is a live virus vaccine and you may get this live, attenuated, weakened form of the measles virus. It may multiply within the host and actually produce an attenuated case of measles, which you can see a week to 12 days after immunization, with a low grade fever and a mild rash. Seroconversion depends upon the age at which MMR vaccine is given. If you give it at a year of age you have excellent immunogenicity. Giving MMR vaccine at six months of age, you can see the seroconversion is only 50%. That’s because many children at six months of age will still have their passively acquired maternal measles antibody, if the mother is immune to measles and therefore this will interfere with vaccine take. It will inactivate the live vaccine so it won’t multiply and you won’t get a good immune response.
Canadian online pharmacy
For measles vaccine, the precautions and contraindications are shown on this slide. Pregnancy; it’s a live vaccine, so theoretical concerns. Gelatin or a mycin allergy, this will be an anaphylactic allergy. That’s in the vaccine. Thrombocytopenia; measles-containing vaccine may cause a lowering of the platelet count, so in a patient with thrombocytopenia you could think about whether it’s worthwhile to vaccinate them against measles or not. Recent immune globulin will interfere with vaccine take. In general, immunocompromised subjects should not get MMR vaccine or measles-containing vaccine. And that’s because it may multiply more than you would want it to. However, HIV infected subjects may be give measles-containing vaccine, unless they are severely immunocompromised. Egg allergy; this is relatively new, over the past few years. Egg allergy in the past had been considered a contraindication of vaccination. No longer, as there is such a small amount of egg protein in the vaccine. Then the issue of the PPD. PPD may be performed on the day of vaccination or one month later. If you do it in between those times, the PPD may not be reliable.
Canadian kamagra
The recommendations for measles vaccine; two doses after the first birthday separated by at least a month, so the general routine is to give the first dose at 12-15 months of age, the second dose, 4-6 years of age. And in an outbreak situation you can give an additional dose at six months of age but this doesn’t count for those two doses after a year of age because, again, the vaccine take is unreliable. This graph from the CDC just shows how successful we’ve been with vaccinating against measles. A marked decline and then here we had a little bit of outbreak of measles and this is where the second dose recommendation came in. It has really been very successful at controlling measles in this country.
Apcalis Oral Jelly at Canadian pharmacy shop.
Now we are going to move on to the second M in MMR, mumps vaccine. This is a slide from the CDC showing a child with parotid gland swelling due to mumps. Mumps does cause salivary gland swelling and also may cause complications – mostly in older individuals – may cause pancreatitis, meningitis, hearing loss as well as orchitis. Mumps vaccine is also a live virus vaccine. Reactions to mumps vaccine are rare. The precautions and complications are similar to what you’ve already heard for measles vaccine; pregnancy, immunocompromised, recent immune globulin will interfere with vaccine take, and the seroconversion is excellent with mumps vaccine. This graph from the CDC also illustrates a marked decline in mumps in this country with routine vaccine. So this has been quite successful.

About whole cell DTP vaccine

Disorders — Sun, 25 Jan 2009 11:35:44 +0000

I’m not going to talk much about whole cell DTP vaccine because it’s the old vaccine. Now what’s recommended and is preferred is to use the acellular vaccine because there are less reactions to it. The whole cell vaccine contains endotoxin and does have more reaction. Given in the same series as the acellular vaccine, has the same contraindications and precautions and similar efficacy. But it does have a lot of reactions, as shown in this table. This is a study by Cody and colleagues showing really the high rates of reaction to whole cell DTP vaccine; up to 50% local reactions, half the patients with fever and then systemic reactions, such as drowsiness, irritability, persistent crying. Again, a lot of these reactions due to endotoxin. Give the acellular pertussis component vaccine, you get less reaction and that’s why it’s preferred. But because it’s so reactagenic, in the past it’s been blamed for a lot of other things. Just to clear up some misconceptions; pertussis-containing vaccines do not cause sudden infant death syndrome. Pertussis-containing vaccines do not cause brain damage. There is no causal link between any pertussis component vaccine and brain damage. In the past some practitioners have given half doses of DTP vaccine in an attempt to prevent reaction. Half doses have not been well studied. The immunogenicity and efficacy of that is not well known and therefore you should not give half doses of vaccine. Give the regular dose.
Human Growth Hormone online
Now polio vaccine; this is also one of these areas that is really in a state of flux, and a good portion of the polio discussion in the syllabus is about OPV, oral polio vaccine, live vaccine. And there are some changes in that regard that are coming up and therefore for Board review purposes, you have to realize it takes a while for these Board tests to catch up with what’s going on. So if you know the latest information, that’s fine. And if you know the old information, that’s fine too. You are not going to be dinked on that if it’s a transitional period and that’s where we are right now, in a transitional period. What you need to know is that the oral, live vaccine is a very good vaccine but it has a rare side effect. And that’s that the oral vaccine may mutate into a virulent form and cause vaccine-associated paralytic polio. This occurs rarely so the benefits of this vaccine outweigh the risks. However, in this day and age when we’ve done such an excellent job in eliminating polio from this country, the risks of vaccine are no longer acceptable. That’s why now we don’t recommend the oral vaccine and as of January 1st 2000, recommend that all four doses of polio vaccinations should be with the killed vaccine, the inactivated polio vaccine administered subcutaneously. The killed vaccine has no risk of reversion to the wild type, virulent strain. No risk of causing paralytic polio. The current schedule, however, – and in the syllabus and on this slide – until Y2K, is to give the first doses of IPV at two months and at four months of age. The second doses, personal choice; either OPV or IPV and I’m not going to go into the logistics of 6-18 months, 12-18 months and 4-6 years. Really what’s going to happen after January 1st is you should just give two months, four months, 6-18 months is the third dose of IPV and 4-6 years for the fourth dose of IPV. And then somebody will be up to date. Until then, the second two doses may be oral polio vaccine.
Female viagra at cheap online pharmacy.
Precautions and contraindications are specific really for the oral polio component, which again is sort of out of date. But IPV should be used only for immunocompromised subjects or household contacts. The oral vaccine may multiply and can be transmitted person to person, and so should not be given if there is anybody immunocompromised, such as with HIV infection, in the household. In pregnancy there is a theoretical risk and so one should avoid vaccination if possible.

Again, tetanus toxoid comes

Disorders — Thu, 22 Jan 2009 18:33:13 +0000

Again, tetanus toxoid comes in a variety of vaccine formulations and to prevent tetanus we really must pay attention to wound care. Cleaning the wound, making sure you debride any devitalized tissue and taking out any foreign body.
Discount lamisil
Finally, you put the D and T together with a pertussis component and you get DTaP vaccine, the acellular pertussis component, and that includes various components of Bordetella pertussis. Including possibly pertussis toxin, filamentous hemagglutinin, pertactin (pertucin?) fimbriae and a variety of combinations of these which we will get to. The main difference with DTaP vaccine and whole cell DTP vaccine is the decreased endotoxin content in the acellular formulation. This is given in a five day series, two for six months, 12-18 months and finally at 4-6 years of age. You do not give pertussis vaccines, at this point, at seven years of age and older. Only less than seven years of age. The efficacy of the DTaP vaccine is similar to DTP vaccine. About 80-95% and the reaction is lower rate to the common reactions compared to the DTP vaccine. Mostly because of the decreased endotoxin content. The DTaP vaccines are shown in this slide. These are all the FDA-approved vaccines. They are all different. They have different names, different manufacturers and different compositions; a variety of different antigens that are produced in different ways, they are in the vaccine in different quantities. For purposes of taking the test, these are all similar in terms of reactagenicity. There is no meaningful clinical differences between the reactagenicity and there are no meaningful differences between the efficacies of these vaccines and immunogenicities of these vaccines for test taking purposes. There is no difference in efficacy. So you really don’t have to spend too much time on the names and all that. But you do need to know that they are all different and they have different composition. The FDA has approved these for different doses. Really, from a practical standpoint, you can use any of these vaccines at any time. And these vaccines are interchangeable, although it is preferable for at least the first three doses to use the same vaccine, but not required.
Nymphomax pharmacy
The relative contraindications to pertussis vaccine are shown in this slide and this is different from an absolute contraindication. Pertussis, as you know, can be a very severe disease. So depending on a risk of a subject to pertussis and the complications that they could get from the disease, you need to weigh the risks and benefits. But prior vaccine reaction is a relative contraindication. That’s encephalopathy within seven days, a seizure within three days, persistent crying for three or more hours, collapse state or hypotonic hypo-responsive episode, fever greater than or equal to 40.5 C or an anaphylactic reaction. These are relative contraindications to further vaccination with any pertussis component vaccine. Anybody with a known or suspected progressive neurologic disorder or recent seizures. If you give the vaccine it may result in fever. Fever lowers the seizure threshold, this may induce the seizure and it may confuse the clinical picture. So anybody with those conditions or a known or suspected neurologic condition that predisposes to seizures or neurologic deterioration – the common example of that is tuberous sclerosis, where somebody may have tuberous sclerosis and may not show any signs or symptoms but you know that they are at risk for developing them – giving the vaccine may result in lowering the seizure threshold and then you are not sure. Was it the vaccine? Was it the disease? So you need to think about that.